X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35167) 35167
Newsletter (133) 133
Magazine Article (121) 121
Newspaper Article (72) 72
Book Chapter (60) 60
Publication (9) 9
Transcript (8) 8
Book / eBook (7) 7
Dissertation (6) 6
Conference Proceeding (5) 5
Web Resource (5) 5
Reference (4) 4
Book Review (3) 3
Government Document (2) 2
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30571) 30571
female (19254) 19254
methotrexate - therapeutic use (15846) 15846
male (15267) 15267
methotrexate (15154) 15154
middle aged (12630) 12630
adult (12291) 12291
methotrexate - administration & dosage (9214) 9214
aged (8534) 8534
antineoplastic combined chemotherapy protocols - therapeutic use (7748) 7748
treatment outcome (6930) 6930
oncology (6037) 6037
rheumatology (5999) 5999
arthritis, rheumatoid - drug therapy (5916) 5916
antirheumatic agents - therapeutic use (5342) 5342
rheumatoid arthritis (5120) 5120
adolescent (4669) 4669
drug therapy, combination (4442) 4442
methotrexate - adverse effects (4397) 4397
child (4284) 4284
chemotherapy (4198) 4198
therapy (3876) 3876
cyclophosphamide - administration & dosage (3070) 3070
immunosuppressive agents - therapeutic use (3049) 3049
animals (2981) 2981
prognosis (2938) 2938
cancer (2843) 2843
retrospective studies (2730) 2730
double-blind (2654) 2654
combined modality therapy (2631) 2631
pharmacology & pharmacy (2597) 2597
care and treatment (2584) 2584
child, preschool (2547) 2547
cyclophosphamide - therapeutic use (2504) 2504
follow-up studies (2461) 2461
doxorubicin - administration & dosage (2430) 2430
time factors (2306) 2306
pregnancy (2267) 2267
drug therapy (2221) 2221
fluorouracil - administration & dosage (2216) 2216
arthritis (2189) 2189
infliximab (2168) 2168
breast neoplasms - drug therapy (2118) 2118
rheumatoid-arthritis (2099) 2099
medicine & public health (2094) 2094
antineoplastic combined chemotherapy protocols - adverse effects (2063) 2063
vincristine - administration & dosage (2053) 2053
hematology (2038) 2038
antineoplastic agents - therapeutic use (2021) 2021
cisplatin - administration & dosage (1993) 1993
drug administration schedule (1984) 1984
remission induction (1951) 1951
etanercept (1892) 1892
risk factors (1840) 1840
antibodies, monoclonal - therapeutic use (1829) 1829
efficacy (1820) 1820
disease (1785) 1785
severity of illness index (1764) 1764
aged, 80 and over (1643) 1643
dose-response relationship, drug (1635) 1635
prospective studies (1626) 1626
tumor necrosis factor-alpha - antagonists & inhibitors (1618) 1618
antirheumatic agents - adverse effects (1616) 1616
research (1603) 1603
patients (1579) 1579
children (1519) 1519
prednisone - therapeutic use (1511) 1511
analysis (1494) 1494
medicine, general & internal (1491) 1491
vincristine - therapeutic use (1479) 1479
dermatology (1475) 1475
survival rate (1449) 1449
trial (1445) 1445
clinical trials as topic (1407) 1407
young adult (1407) 1407
immunology (1377) 1377
health aspects (1373) 1373
rheumatoid factor (1364) 1364
psoriasis - drug therapy (1358) 1358
mice (1294) 1294
disease-free survival (1288) 1288
survival analysis (1278) 1278
infant (1255) 1255
antineoplastic combined chemotherapy protocols - administration & dosage (1249) 1249
cyclophosphamide (1239) 1239
chemotherapy, adjuvant (1228) 1228
fluorouracil - therapeutic use (1218) 1218
neoplasm staging (1211) 1211
prednisone - administration & dosage (1209) 1209
pediatrics (1206) 1206
methotrexate - pharmacology (1204) 1204
doxorubicin (1176) 1176
diagnosis (1174) 1174
psoriasis (1171) 1171
cisplatin (1168) 1168
adalimumab (1159) 1159
safety (1146) 1146
dosage and administration (1126) 1126
management (1107) 1107
clinical trials (1106) 1106
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32100) 32100
German (1116) 1116
Japanese (783) 783
French (737) 737
Russian (325) 325
Spanish (312) 312
Italian (271) 271
Chinese (226) 226
Polish (174) 174
Portuguese (72) 72
Dutch (61) 61
Danish (40) 40
Hungarian (37) 37
Czech (28) 28
Hebrew (27) 27
Bulgarian (20) 20
Norwegian (19) 19
Finnish (15) 15
Swedish (15) 15
Serbian (14) 14
Croatian (13) 13
Korean (9) 9
Romanian (8) 8
Slovak (4) 4
Turkish (4) 4
Greek (2) 2
Icelandic (2) 2
Lithuanian (2) 2
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Estonian (1) 1
Latin (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2017, Volume 2017, Issue 5, p. CD012657
Journal Article
The Medical clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 475 - 496
Over the past several decades, rheumatology has directed its focus to understanding and countering the immune dysregulation underlying autoimmune diseases with... 
Biologic response modifiers | Systemic lupus erythematosus | Vasculitis | Disease-modifying antirheumatic drugs | Biologics | Rheumatoid arthritis | SYSTEMIC-LUPUS-ERYTHEMATOSUS | RITUXIMAB THERAPY | 5-AMINOSALICYLIC ACID | REFRACTORY NEUROSARCOIDOSIS | ADENOSINE RECEPTORS | MEDICINE, GENERAL & INTERNAL | TUMOR-NECROSIS-FACTOR | COMBINATION TREATMENT | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Hydroxychloroquine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Certolizumab Pegol | Rheumatic Diseases - drug therapy | Colchicine - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Methotrexate - therapeutic use | Polyethylene Glycols - therapeutic use | Cyclophosphamide - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Infliximab | Minocycline - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - therapeutic use | Rheumatic Diseases - immunology | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Immunoglobulin G - therapeutic use | Rituximab | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Isoxazoles - therapeutic use | Adalimumab | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2017, Volume 2019, Issue 10, p. CD003280
Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a disease that causes progressive or relapsing and remitting weakness and... 
Immunologic Factors | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic inflammatory demyelinating polyradiculopathy | Immunosuppressive Agents | Chronic inflammatory demyelinating polyradiculoneuropathy | Interferon beta‐1a | Treatment Outcome | Immunosuppressive and immunomodulatory treatment | Randomized Controlled Trials as Topic | Neurology | Interferon‐beta | Anti‐Inflammatory Agents | Azathioprine | Methotrexate | Medicine General & Introductory Medical Sciences | Immunoglobulins, Intravenous | Peripheral Neuropathy | SYSTEMIC-LUPUS-ERYTHEMATOSUS | Interferon-beta [therapeutic use] | Immunologic Factors [therapeutic use] | Humans | GUILLAIN-BARRE-SYNDROME | Immunosuppressive Agents [therapeutic use] | Anti-Inflammatory Agents [therapeutic use] | Azathioprine [therapeutic use] | RANDOMIZED CONTROLLED TRIAL | DISEASE-MODIFYING THERAPY | MEDICINE, GENERAL & INTERNAL | Interferon beta-1a | HIGH-DOSE CYCLOPHOSPHAMIDE | INTRAVENOUS IMMUNOGLOBULIN | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [drug therapy] | TERM-FOLLOW-UP | PLACEBO-CONTROLLED TRIAL | STEM-CELL TRANSPLANTATION | Methotrexate [therapeutic use] | MYCOPHENOLATE-MOFETIL | Interferon-beta - therapeutic use | Azathioprine - therapeutic use | Interferon beta-1a - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Immunosuppressive Agents - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Anti-Inflammatory Agents - therapeutic use | Methotrexate - therapeutic use | Immunologic Factors - therapeutic use
Journal Article
2005, Volume 6, Issue 2, 11
.... Since there are almost no randomized, controlled, double-blind studies comparing the use of various therapeutic agents in this condition, treatment decisions still rely heavily on individual clinicians experience... 
Methotrexate, therapeutic use | Mitomycin, therapeutic use | Tetracyclines, therapeutic use | Sulfasalazine, therapeutic use | Tacrolimus, therapeutic use | Nicotinamide, therapeutic use | Cyclophosphamide, therapeutic use | Mycophenolate mofetil, therapeutic use | Pemphigoid, treatment | Calcineurin inhibitors, therapeutic use | Azathioprine, therapeutic use | Leflunomide, therapeutic use | Immunoglobulins, therapeutic use | Interferon alpha 2b, therapeutic use | Corticosteroids, therapeutic use | Sulfapyridine, therapeutic use | Sulfamethoxypyridazine, therapeutic use | Thalidomide, therapeutic use | Ciclosporin, therapeutic use | Prednisone, therapeutic use | Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | PLASMA-EXCHANGE | IMMUNOSUPPRESSIVE THERAPY | TOPICAL CYCLOSPORINE | MITOMYCIN-C | PASSIVE TRANSFER | INTRAVENOUS IMMUNOGLOBULIN THERAPY | SYSTEMIC CHEMOTHERAPY | THALIDOMIDE THERAPY | NECROSIS-FACTOR-ALPHA | MYCOPHENOLATE-MOFETIL | DERMATOLOGY | Calcineurin Inhibitors | Pemphigoid, Benign Mucous Membrane - therapy | Antibiotics, Antineoplastic - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Mitomycin - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Administration, Topical | Tetracyclines - therapeutic use | Plasmapheresis
Book Review
Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Journal Article